CIDRAP newsletters options
The vaccine was 70.4% effective against symptomatic B117 and 81.5% against other strains.
Also, the WHO says ivermectin should be used only to treat COVID-19 within clinical trials.
Racial and ethnic differences in intention to receive a COVID-19 vaccine were comparable across both healthcare workers (HCWs) and the general public in the San Francisco Bay area this winter, according to survey results published yesterday in JAMA Internal Medicine.
The UK and South Korea report fewer primary care, emergency visits, 3 studies say.
"The failure to take this virus seriously is precisely what got us into this mess in the first place."
Experts say a jump from an intermediate animal carrier is the likeliest scenario.
An analysis of neighborhood-level data in three US cities highlights the racial and socioeconomic disparities in COVID-19 positivity, incidence, and mortality, researchers reported today in the Annals of Internal Medicine.
Also, Brazilian researchers warned of a link between the P1 variant and higher death rates in younger adults.
"We can win this by hanging in there a bit longer," medical adviser Anthony Fauci says.
Antibodies from both recovered and vaccinated people neutralized the UK variant better than the South African one.
The results of a randomized clinical trial conducted in France indicate that 3 days of beta-lactam therapy is non-inferior to 8 days of treatment in patients hospitalized with community-acquired pneumonia who meet clinical stability criteria after 3 days, French investigators reported last week in The Lancet Infectious Diseases.
Adults 20 to 49 years old may be sustaining the resurgence of COVID-19, according to a study published late last week in Science.
The lawsuit involves the EPA's decision to allow widespread use of a medically important antibiotic to prevent and treat citrus diseases.
Antibody response was akin to that in non-pregnant women, with a similar safety profile.
The WHO issues an urgent request for countries to donate 10 million vaccine doses in a final push to get inital vaccine to all countries.
Also, the CDC notes higher anxiety and depression in young adults during the pandemic.
Interviews with clinicians at hospitals in three low- and middle-income countries highlight some of the barriers to appropriate antibiotic prescribing in these settings, according to a study published yesterday in Antimicrobial Resistance & Infection Control.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
Researchers reporting on two non-peer–reviewed studies published this week on the preprint server medRxiv followed up months after adults' COVID-19 hospitalization and found that 55% to 71% have not fully recovered. Middle age and female sex were associated with a higher likelihood of worse recovery in both studies.
Patients given the antiviral drug improved in 5 days, compared with 7 days in the control group.
